Business & Consumer Services » Business Services | Syngene International Ltd.

Syngene International Ltd. | Mutual Funds

Mutual Funds that own Syngene International Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
UTI - Mid Cap Fund
1,389,368
0.7%
51,000
2.04%
08/31/2018
HSBC GIF - Indian Equity
1,302,071
0.65%
-129,729
0.61%
10/31/2017
Aberdeen Global - Asian Smaller Companies Fund
864,000
0.43%
864,000
0.48%
05/31/2018
UTI - Equity Fund
812,667
0.41%
40,000
0.55%
08/31/2018
Aberdeen Global - Emerging Markets Smaller Companies Fund
800,000
0.4%
200,000
0.9%
05/31/2018
752,279
0.38%
17,010
1.24%
03/31/2018
Reliance Pharma Fund
621,752
0.31%
502,358
1.41%
08/31/2018
Vanguard Total International Stock Index Fund
607,739
0.3%
0
0%
07/31/2018
Jupiter India Fund
578,739
0.28%
5,150
0.39%
02/28/2018
Vanguard Emerging Markets Stock Index Fund
576,503
0.28%
-7,700
0.01%
07/31/2018

About Syngene International

View Profile
Address
Biocon Park , Plot 2&3, Phase-IV
Bangalore Karnataka 560099
India
Employees -
Website http://www.syngeneintl.com
Updated 09/14/2018
Syngene International Ltd. operates as a contract research organization, which provides discovery and development services for novel molecular entities. Its services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.